- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- P-ethoxy growth factor receptor-bound protein 2 antisense ol
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
P-ethoxy growth factor receptor-bound protein 2 antisense oligonucleotide
| EU orphan designation number: | EU/3/16/1758
|
| Active ingredient: | P-ethoxy growth factor receptor-bound protein 2 antisense oligonucleotide |
| Indication: | Treatment of acute myeloid leukaemia |
| Sponsor: | Clinical Network Services (UK) Ltd
Fountain Court, 2 Victoria Square, Victoria Street, St Albans AL1 3TF, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 18/10/2016 | Orphan designation | EMA/OD/155/16 | (2016)6750 of 14/10/2016 |
CONTACT
EU links
Directorate General Health & Consumers